-
Most Popular
Penny Stocks
Penny stocks trade at less than $5 per share. They are highly volatile and incredibly risky investments that can burn new and seasoned investors alike; they often serve as the playground for scam artists and market manipulators. However, while penny stocks can be halved in the blink of an eye, they can also double much more quickly than large-cap stocks. Investors interested in penny stocks should be aware of the risks and do their due diligence before making an investment. Read on to find out how to profit without getting scammed.
7 Space Exploration Stocks That Could Pioneer New Frontiers
Explore space exploration stocks with potential for significant growth as global competition in space technology increases.
3 Stocks to Buy That Could Turn Your Beer Money Into Champagne Showers
These three high-potential stocks could potentially turn a small investment into significant returns. Consider throwing in some beer money.
3 Stocks Under $15 That Could Make You a Millionaire
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
Other Stock Types you might be interested in
Recent Penny Stocks Articles
Grab Naked Brands Stock If It Tops a Dollar Without Splitting
NAKD stock is 85% below its 52-week high of $3.40 per share. And it is a low valued penny stock at its current level of $0.52. However, the Australian company has received some positive attention, and a slight bump in its share price, after it succeeded in offloading its Bendon subsidiary, a money losing brick-and-mortar retail operation. This divestiture frees up Naked Brand to sell its swimwear and lingerie apparel exclusively online.
Zomedica’s Risks Are Too Big to Ignore
You may like ZOM stock as a pet lover, but not for its fundamentals, nor its valuation until it starts having credible financial results.
Zomedica’s High Share Count Creates Challenges for ZOM Stock
Zomedica has promising growth potential, but its high share count makes ZOM stock a risky investment. Here's what investors should know.
This Significant New Partnership Makes Senseonics Stock Worth Another Look
SENS stock has much stronger fundamentals than your average penny stock. This diabetes care firm could rally again in coming months.
Target Highly Promising Antiviral Therapeutics with Cocrystal Pharma
A buying opportunity is here as COCP stock is down, even as Cocrystal makes progress in developing a potentially lifesaving antiviral drug.
SOS Stock Simply Faces Too Many Obstacles
SOS stock was falling before the recent selloff in cryptocurrencies. Recent financial results are encouraging, but the stock still looks overvalued.
Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing
Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1?
Naked Brand Group Stock Will Split Eventually, and Then You’ll Really Be Stuck
Nasdaq issued Naked Brand Group notice of minimum bid price non-compliance on April 29. Odds are good NAKD stock is about to reverse split.
Acquisition Will Make Ideanomics a Prime Renewable Energy Investment
Ideanomics invests in multiple high-growth sectors, including clean transportation, making the IDEX stock price dip a buying opportunity.
Let Naked Brands Be a Lesson to You
NAKD stock got lucky when r/WallStreetBets launched a short squeeze on it. Now Naked Brands needs to turn the cash from that into a business.
Zomedica Stock Will Burn You as High-Growth Stocks Start to Flag
The bull market has certainly made new investors look like geniuses, as usual. But now is the true test and ZOM stock isn't likely to pass.
Zomedica Stock Is Clearly Going to Keep Moving in the Wrong Direction
The share price of the Ann Arbor, Michigan-based animal health company has now gone from a pullback and into a steep decline. Since March 15th, ZOM stock has fallen 68% and is now below the $1 threshold at just $0.79 per share. Given the precarious situation, investors should steer clear of this security for now.
Sundial Growers Stock Is Doomed To Continually Disappoint Investors
SNDL Stock continues to disappoint its investors with its horrible earning results and its deplorable outlook
